| Literature DB >> 30363924 |
Christopher Kobylecki1,2, Dinesh Damodaran1, Bronwyn Kerr3, Richard W Newton4, Monty A Silverdale1,2.
Abstract
We report on a large family with myoclonus-dystonia resulting from an epsilon-sarcoglycan mutation, with prominent early and late lower-limb involvement. The proband's condition has evolved to include marked lower-limb dystonia and dystonic gait impairment in the fourth decade. Other family members had evidence of prominent lower-limb involvement at presentation or a more typical phenotype of axial and upper-limb myoclonus and dystonia. Prominent lower-limb involvement developing late in the disease course is an atypical feature and exemplifies the wide phenotypic heterogeneity observed in people with myoclonus-dystonia.Entities:
Keywords: epsilon‐sarcoglycan; gait disorder; myoclonus‐dystonia
Year: 2014 PMID: 30363924 PMCID: PMC6183303 DOI: 10.1002/mdc3.12022
Source DB: PubMed Journal: Mov Disord Clin Pract ISSN: 2330-1619